Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lu Daopei Hematology Hospital is a leading private specialized hospital group in China, founded by Professor Lu Daopei, a pioneer in bone marrow transplantation. The institution is globally recognized for its expertise in hematopoietic stem cell transplantation (HSCT) and is one of the most active clinical research centers for CAR-T cell therapies in the world. Operating multiple facilities in Beijing and Langfang, the hospital provides a full spectrum of services including advanced hematopathology, genomic testing, and intensive care for complex blood disorders. It serves as a critical hub for translational medicine, collaborating with global biotech partners to advance novel immunotherapies for refractory leukemia and lymphoma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Ludapei Hematology Hospital.